Variant report
Variant | esv3436467 |
---|---|
Chromosome Location | chr20:24791752-24796050 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112912459 | chr20:24791779-24791780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575882744 | chr20:24791781-24791782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73335473 | chr20:24791787-24791788 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs185851536 | chr20:24791789-24791790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190264762 | chr20:24791793-24791794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556209496 | chr20:24791799-24791800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540181239 | chr20:24791804-24791805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559905016 | chr20:24791853-24791854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532404033 | chr20:24791868-24791869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201699393 | chr20:24791874-24791875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562472235 | chr20:24791879-24791880 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139689138 | chr20:24791905-24791906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548028104 | chr20:24791965-24791966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567375822 | chr20:24792003-24792004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181140938 | chr20:24792043-24792044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186056044 | chr20:24792108-24792109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs13042976 | chr20:24792160-24792161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13044163 | chr20:24792162-24792163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566773323 | chr20:24792195-24792196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6114878 | chr20:24792203-24792204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539048999 | chr20:24792251-24792252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11473927 | chr20:24792259-24792260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559276080 | chr20:24792306-24792307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73101427 | chr20:24792351-24792352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs11477951 | chr20:24792358-24792359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75093709 | chr20:24792360-24792361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73903981 | chr20:24792375-24792376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574546445 | chr20:24792376-24792377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539970512 | chr20:24792407-24792408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71335540 | chr20:24792415-24792416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112853659 | chr20:24792427-24792428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6114879 | chr20:24792430-24792431 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs111711418 | chr20:24792454-24792455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548328350 | chr20:24792615-24792616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182411378 | chr20:24792633-24792634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562433536 | chr20:24792685-24792686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs202184023 | chr20:24792737-24792738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187423270 | chr20:24792755-24792756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191030945 | chr20:24792760-24792761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183184897 | chr20:24792818-24792819 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112412876 | chr20:24792826-24792827 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187476709 | chr20:24792834-24792835 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34197041 | chr20:24792908-24792909 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553926962 | chr20:24792988-24792989 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6049989 | chr20:24793011-24793012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6049990 | chr20:24793033-24793034 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs532390383 | chr20:24793046-24793047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6049991 | chr20:24793062-24793063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544965931 | chr20:24793077-24793078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6049992 | chr20:24793080-24793081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:24791400-24791800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr20:24791400-24792000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr20:24791400-24792200 | Enhancers | Spleen | Spleen |
4 | chr20:24791600-24793800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr20:24791800-24793600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr20:24792000-24793800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr20:24792200-24792600 | Weak transcription | Spleen | Spleen |
8 | chr20:24792600-24792800 | Enhancers | Spleen | Spleen |
9 | chr20:24792800-24793000 | Flanking Active TSS | Spleen | Spleen |
10 | chr20:24793000-24793800 | Enhancers | Spleen | Spleen |
11 | chr20:24793600-24794200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr20:24793800-24794000 | Genic enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr20:24793800-24794000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr20:24793800-24794200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr20:24793800-24794200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
16 | chr20:24793800-24796600 | Weak transcription | Spleen | Spleen |
17 | chr20:24794000-24794200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr20:24794200-24796600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr20:24794200-24797000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
20 | chr20:24794200-24817600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |